United States Prescription Drugs

• United States Pain Management Therapeutics Market, Forecast 2022-2028, Industry Trends, Outlooks, Impact of COVID-19, Company Analysis

  Mar 01, 2022  |  Published by: Renub Research  |  USD 2,490

  ... has faced a crisis in the United States for years due to severe problems accessing sufficient care, resulting in considerable physical, emotional, and societal expenses. To treat pain caused by inflammation in reaction to tissue ... Read More

• Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2028, NAIC 424200

  Feb 11, 2022  |  Published by: Plunkett Research, Ltd.  |  USD 2,495

  ... numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $1,687,403 million by 2028. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry ... Read More

• Global and United States Eosinophilic Asthma Treatment Market Size, Status and Forecast 2021-2027

  Jan 21, 2022  |  Published by: QYResearch Group  |  USD 3,900

  ... In 2020, the global Eosinophilic Asthma Treatment market size was US$ 9901 million and it is expected to reach US$ 98355 million by the end of 2027, with a CAGR of 38.99% during 2021-2027. In ... Read More

• U.S. E-Prescribing Market - Industry Outlook & Forecast 2022-2027

  Jan 18, 2022  |  Published by: Arizton Advisory and Intelligence  |  USD 3,500

  ... grow at a CAGR of 20.68% during the period 2022–2027. U.S. E-PRESCRIBING INDUSTRY INSIGHTS E-prescribing uses healthcare technologies to improve prescription accuracy, enhance patient safety, and ensure cost savings. Also, e-prescribing allows real-time, secure, and ... Read More

• Out-of-Pocket Healthcare Expenditures in the United States, 5th Edition

  Jul 01, 2021  |  Published by: Kalorama Information  |  USD 3,000

  ... States, 5th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures ... Read More

• Pet Medications: United States

  Jun 30, 2021  |  Published by: Freedonia Focus Reports  |  USD 900

  ... the retail market for medications for domestic dogs and cats, centering on products purchased directly by consumers. These include prescription, over-the-counter (also called OTC or retail), and ""ethical"" products (nonprescription medications that are only distributed ... Read More

• Pharmaceuticals: United States

  Mar 01, 2018  |  Published by: Freedonia Focus Reports  |  USD 900

  ... compounded and biological. Compounded pharmaceutical demand is also segmented by therapeutic class as follows: hormones and related, central nervous system, anti-infective, cardiovascular, respiratory, nutritional, digestive and genito-urinary, and dermatological. To illustrate historical trends, total demand, ... Read More

• Pharmaceuticals Market USA Sep 2017

  Sep 01, 2017  |  Published by: Plunkett Research, Ltd. Special Reports  |  USD 1,995

  ... market in the USA with deep market research. Provides expert insight into market drivers, challenges, and the competitive landscape facing the market with data from 2016. The purpose of this report is to provide deep ... Read More

• Pet Medications in the U.S., 5th Edition

  Aug 25, 2017  |  Published by: Packaged Facts  |  USD 3,196

  ... and cats, with a particular focus on brand-name products used by consumers. These include prescription, over-the-counter (OTC or “retail”), and ethical products (nonprescription medications whose distribution is restricted by the manufacturer to veterinarians). The primary ... Read More

• Dermatological Drugs: United States

  Jun 30, 2017  |  Published by: Freedonia Focus Reports  |  USD 900

  ... drugs, skin cancer drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, hair loss and hair removal drugs, hyperpigmentation/melasma and depigmenting drugs, and other products. To illustrate historical trends, total demand and the various segments ... Read More

• Sleep Management in the U.S.: Consumer Strategies

  Feb 17, 2017  |  Published by: Packaged Facts  |  USD 2,000

  ... that 82% of adults have trouble sleeping at least once a week, due to at least one of seven forms of sleep disturbance. This translates to 206 million “troubled sleepers” out of 249 million U.S. ... Read More

• Pain Management in the U.S.: Consumer Strategies

  Jan 30, 2017  |  Published by: Packaged Facts  |  USD 1,600

  ... report studies two distinct groups: pain sufferers and adults who have selected illnesses/conditions strongly associated with physical pain and pain management. Demographic analysis of these groups is woven into report analysis. Content is further segmented ... Read More

< prev 1 2 3 4 next >